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Abstract. 
 
The dystrophin-associated protein (DAP)
complex spans the sarcolemmal membrane linking the
cytoskeleton to the basement membrane surrounding
each myoﬁber. Defects in the DAP complex have been
linked previously to a variety of muscular dystrophies.
Other evidence points to a role for the DAP complex in
 
formation of nerve–muscle synapses. We show that myo-
tubes differentiated from dystroglycan
 
2
 
/
 
2
 
 embryonic
stem cells are responsive to agrin, but produce acetyl-
choline receptor (AChR) clusters which are two to
three times larger in area, about half as dense, and sig-
niﬁcantly less stable than those on dystroglycan
 
1
 
/
 
1
 
myotubes. AChRs at neuromuscular junctions are simi-
larly affected in dystroglycan-deﬁcient chimeric mice
and there is a coordinate increase in nerve terminal size
at these junctions. In culture and in vivo the absence of
dystroglycan disrupts the localization to AChR clusters
of laminin, perlecan, and acetylcholinesterase (AChE),
 
but not rapsyn or agrin. Treatment of myotubes in
culture with laminin induces AChR clusters on dys-
troglycan
 
1
 
/
 
1
 
, but not 
 
2
 
/
 
2
 
 myotubes. These results
suggest that dystroglycan is essential for the assembly
of a synaptic basement membrane, most notably by lo-
calizing AChE through its binding to perlecan. In addi-
tion, they suggest that dystroglycan functions in the or-
ganization and stabilization of AChR clusters, which
appear to be mediated through its binding of laminin.
Key words: synapse formation • acetylcholinesterase
• acetylcholine receptors • dystroglycan • dystrophin-
associated proteins
 
Introduction
 
The neuromuscular junction (NMJ)
 
1 
 
encompasses three
distinct domains specialized in the efficient transmission of
signals from motor neuron to muscle: the nerve terminal,
the synaptic basement membrane, and the postsynaptic
 
membrane. During development
 
 
 
all three regions differ-
entiate after release of agrin (McMahan, 1990), a heparan
sulfate proteoglycan (Denzer et al., 1995), by the nerve.
Agrin becomes concentrated in the synaptic basement
membrane where it can interact with molecules on the
postsynaptic membrane to initiate the formation of a high
density of acetylcholine receptors (AChRs) at sites of
nerve–muscle contact (Gautam et al., 1996).
Aggregates of AChRs at mature NMJs are metaboli-
cally and diffusionally very stable (Berg and Hall, 1975;
Salpeter and Harris, 1983; Akaaboune et al., 1999) and are
thought to accumulate in the differentiating postsynaptic
membrane by diffusion into a “trap” of membrane-cyto-
 
skeletal proteins (Edwards and Frisch, 1976). This accumula-
tion of AChRs in vivo and in culture progresses through
two stages. In the first, AChRs assemble into microclus-
ters, which are subsequently condensed and maintained as
larger clusters
 
 
 
(Anderson and Cohen, 1977; Steinbach,
1981; Wallace, 1988; Cohen et al., 1995; Jacobson et al.,
1998). The initial event in the formation of AChR clusters
is believed to be the activation of the receptor tyrosine ki-
nase, muscle-specific tyrosine kinase (MuSK), by agrin
(Valenzuela et al., 1995; Zhou et al., 1999). The cytoplas-
mic extensions of AChRs are associated with rapsyn (Bur-
den et al., 1983), a protein which can aggregate to mediate
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the formation of AChR microclusters (Froehner et al.,
1990; Phillips et al., 1991a).
Also contained within microclusters are the dystrogly-
cans, two members of a complex of dystrophin-associated
proteins (DAPs) which are found over the entire sarco-
lemma, but are concentrated at NMJs (Ohlendieck et al.,
1991; Matsumura et al., 1992). Encoded by a single gene,
the dystroglycan precursor is posttranslationally cleaved
to produce the extracellular peripheral membrane protein
 
a
 
-dystroglycan and the transmembrane protein 
 
b
 
-dystro-
glycan (Ibraghimov-Beskrovnaya et al., 1992; Gorecki et
al., 1994; Deyst et al., 1995). These two proteins are bound
noncovalently and span the membrane to interact with
both the extracellular matrix and cytoskeleton (Ibraghi-
mov-Beskrovnaya et al., 1992; Henry and Campbell,
1999). As such, the dystroglycans form the core of a larger
complex of DAPs that function to maintain muscle integ-
rity (Henry and Campbell, 1996) and mediate basement
membrane assembly (Williamson et al., 1997) in a variety
of tissues, including skeletal muscle (Cohen et al., 1997;
Henry and Campbell, 1998; Montanaro et al., 1998; Côté
et al., 1999). DAPs have been widely studied since their
dysfunction leads to muscular dystrophies (Sunada and
Campbell, 1995), but they also have been implicated in the
formation of NMJs. This was suggested by evidence that
 
a
 
-dystroglycan binds agrin (Bowe et al., 1994; Campanelli
et al., 1994; Gee et al., 1994; Sugiyama et al., 1994) and
helps mediate AChR clustering (Campanelli et al., 1994;
Gee et al., 1994; Montanaro et al., 1998) during synapse
formation in culture (Cohen et al., 1995). More recently,
Côté et al. (1999) reported that mouse muscles deficient in
dystroglycans have severely disorganized NMJs. In keep-
ing with this, Grady et al. (2000) showed recently that mice
null for the DAP dystrobrevin also have disrupted NMJs.
The importance of the dystroglycans in synaptic base-
ment membrane assembly has been highlighted by two re-
lated observations. First, laminins are major components
of basement membranes (Yurchenco and O’Rear, 1994;
Timpl, 1996) and 
 
a
 
-dystroglycan is a laminin receptor
(Smalheiser and Schwartz, 1987; Douville et al., 1988;
Ibraghimov-Beskrovnaya et al., 1992). Second, laminin
and 
 
a
 
-dystroglycan can coassemble on the cell surface
(Cohen et al., 1997; Montanaro et al., 1998; Colognato et
al., 1999) as well as bind other matrix molecules, including
collagen, entactin, and perlecan (Peng et al., 1998; Talts et
al., 1999). Acetylcholinesterase (AChE) is another impor-
tant basement membrane protein that is localized to NMJs
via its collagen tail (Massoulié et al., 1993). Indeed, when
histological sections of muscle are incubated with the col-
lagen-tailed AChE the enzyme attaches specifically to the
sites of nerve–muscle contact on the basement membrane
(Rotundo et al., 1997). It was subsequently shown that the
AChE molecules can bind to perlecan, which in turn can
bind to 
 
a
 
-dystroglycan. These interactions have been pro-
posed to account for synaptic localization of AChE (Peng
et al., 1999). In addition, extracellular matrix assembly
may also be involved in AChR clustering at sites of nerve–
muscle contact since treatment of myotubes in culture
with exogenous laminin stimulates AChR aggregation
(Vogel et al., 1983) via dystroglycan and independent of
MuSK activation (Cohen et al., 1997; Sugiyama et al.,
1997; Montanaro et al., 1998).
 
In this study we further define the role of dystroglycans
in AChR clustering and basement membrane assembly us-
ing chimeric mice with reduced dystroglycan expression
and myotubes generated from dystroglycan-null embry-
onic stem (ES) cells. Dystroglycan-deficient muscle and
dystroglycan-null myotubes were both found to have
AChR clusters on their surfaces, though they are com-
prised of loosely associated microclusters. In culture the
absence of dystroglycan did not markedly affect the initia-
tion of AChR clustering by agrin, nor did it affect the colo-
calization of agrin and rapsyn with AChR clusters, sug-
gesting that dystroglycan functions downstream of agrin
and rapsyn by condensing AChR microclusters. However,
there was a significant decrease in AChR cluster stability
on dystroglycan-null myotubes compared with wild-type
controls. This evidence is consistent with a proposed role
for dystroglycan in mediating cytoskeletal and possibly
basement membrane interactions which trap AChRs (Car-
bonetto and Lindenbaum, 1995). Furthermore, in muscle
myotubes, components of the synaptic basement mem-
brane, including laminin, perlecan, and AChE, were no
longer concentrated at AChR clusters, although the distri-
bution of laminin and perlecan over the rest of the myo-
tube appeared unaffected. We conclude that dystroglycans
not only are necessary for AChR cluster condensation and
stability, but they also coordinate assembly of the synaptic
basement membrane.
 
Materials and Methods
 
Dystroglycan-null ES Cell Generation
 
ES cell lines rendered null for dystroglycan were described previously
(Côté et al., 1999). In brief, targeting vectors were generated by excising a
10.2-kb EcoR1 fragment containing exon 2 and portions of the flanking
introns from a 17.5-kb clone isolated from a mouse genomic library. Two
vectors were generated. The first was constructed by replacing a 0.7-kb
Stu1–Sal1 fragment with the hygromycin-resistance gene (
 
hygro
 
r
 
). This re-
moved the dystroglycan coding sequence corresponding to amino acids
92–117, as well as the splice donor site. In the second vector, the coding se-
quence corresponding to amino acids 100–117, located between two Sac1
sites, was replaced with the neomycin-resistance gene (
 
neo
 
r
 
). The 
 
hygro
 
r
 
and the 
 
neo
 
r
 
 
 
vectors were linearized and R1 ES cells (Nagy et al., 1993)
were electroporated with the 
 
hygro
 
r
 
 vector first. Hygromycin-resistant
clones were picked, expanded, and screened for homologous recombina-
tion events using a 0.7-kb EcoR1-Xho1 fragment to hybridize HindIII-
digested DNA. A single clone (2D8) was chosen and electroporated with
the 
 
neo
 
r
 
 vector. We repeated the selection procedure with G418 sulfate
and identified homologous recombinant clones using the same 0.7-kb
EcoR1-Xho1 fragment as a probe. Two null dystroglycan clones, 3C12
and 3H1, were selected for differentiation in culture.
 
Cell Culture and ES Cell Differentiation
 
Wild-type R1 ES cells and dystroglycan-null 3C12 and 3H1 cells were
maintained in a totipotent state by cultivating them as described previ-
ously (Abbondanzo et al., 1993). In brief, ES cells were seeded over a
layer of neomycin-resistant or neomycin/hygromycin-resistant feeder fi-
broblasts. The ES cells were fed daily with DME high glucose medium
supplemented with 20% ES-cell–qualified FCS (Wisent Canadian Labo-
ratories), 
 
L
 
-glutamine (2 mM; Life Technologies), 2-mercaptoethanol
(10
 
2
 
4 
 
M; Sigma-Aldrich), and leukemia inhibitory factor (1,000 U/ml; Life
Technologies). ES cells were induced to form embryoid bodies as de-
scribed by Rohwedel et al. (1994), with modifications taken from Dins-
more et al. (1996). ES cells were harvested and fibroblast feeders were re-
moved by preplating twice onto gelatin (0.1%)-coated tissue culture
dishes. After a 1-h incubation the ES cells were washed off with medium
and diluted to a concentration of 4
 
 3 
 
10
 
4
 
 cells/ml of differentiation me-
dium (DME high glucose supplemented with 15% horse serum; Wisent 
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Canadian Laboratories), 1% DMSO (Sigma-Aldrich), and 1% penicillin-
streptomycin (Life Technologies). Aliquots (20 
 
m
 
l) of cell suspension
were spotted as drops onto the undersides of lids from 100-mm bacterial
petri dishes (Fisher Scientific), which were then inverted over dishes filled
with medium to prevent drying. The ES cells were cultivated in this man-
ner for 4 d, then transferred to gelatin (0.1%)-coated tissue culture dishes
and cultured for an additional 20–30 d. Differentiating ES cell bodies were
maintained in DME high glucose supplemented with 15% horse serum
(Wisent Canadian Laboratories) and 1% penicillin-streptomycin.
 
Antibodies and Toxins
 
TRITC and Alexa 488–conjugated 
 
a
 
-bungarotoxin (
 
a
 
-Btx) and TRITC
and Oregon green secondary antibodies were obtained from Molecular
Probes. Anticollagen IV and antiperlecan (1948) antibodies were pur-
chased from Chemicon International. The antifibronectin antibody was
obtained from Telios Pharmaceuticals. The antisynaptophysin antiserum
was purchased from Novocastra Laboratories. Fasciculin 2 (fas-2; Sigma-
Aldrich) was labeled with TRITC or Oregon green (Molecular Probes) as
described previously (Peng et al., 1999). The antisera to laminin 
 
a
 
2 chain
(merosin) and agrin were generously provided by P. Yurchenco (Robert
Wood Johnson Medical School, Piscataway, NJ) and Z. Hall (University
of California at San Francisco, San Francisco, CA), respectively. The anti-
laminin and the antidystroglycan antisera were generated in house by in-
oculating rabbits with Engelbreth-Holm-Swarm (EHS) laminin or a
polypeptide corresponding to 15 of the last 16 amino acids of the COOH
terminus of 
 
b
 
-dystroglycan, respectively. Finally, the antirapsyn mono-
clonal antibody 1234 was a gift from S. Froehner (University of North
Carolina, Chapel Hill, NC).
 
Labeling of Muscle Fibers with 
 
a
 
-Btx and Fas-2
 
Intact muscles were dissected, pinned out at resting length, and fixed in
4% paraformaldehyde in 20 mM PBS, pH 7.4. For labeling, bundles of fi-
bers were teased apart and incubated in PBS to remove fixative. The fi-
bers were then washed with PBS containing 10% horse serum (PBS/HS)
and stained for 30 min in PBS/HS containing 0.5–1.0 
 
m
 
g/ml TRITC–
 
a
 
-Btx
and Oregon green–conjugated fas-2 each. The fiber bundles were then
washed three times in PBS/HS, twice with PBS alone, and fixed again for
15 min at room temperature with 4% paraformaldehyde in 20 mM PBS.
The fibers were then teased apart to give single fibers and mounted in
90% glycerol buffered with 10 mM bicarbonate, pH 9.5, containing 1 mg/
ml 
 
p
 
-phenylenediamine to reduce photobleaching. The specimens were
then viewed with a Leica DMR-AX microscope at 40–100
 
3
 
. The images
were captured using a Princeton Instruments MicroMax CCD camera and
analyzed using Metamorph software (Universal Imaging Corp.).
 
Immunocytochemistry
 
Fresh-frozen, superficial gluteal muscles from chimeric mice
 
 
 
aged be-
tween 3 and 12 wk were sectioned longitudinally (10 
 
m
 
m), blocked with
10% goat serum, and stained with TRITC–
 
a
 
-Btx and affinity-purified an-
tidystroglycan antiserum, followed by an Oregon green 488–conjugated
secondary antiserum. Myotubes from differentiated ES cells were incu-
bated at 37
 
8
 
C with agrin (500 pM; a gift from M. Ferns, McGill University;
Ferns et al., 1993) or EHS laminin (100 nM; Timpl et al., 1982) overnight
in ES cell differentiation medium. In all cases AChRs were visualized by
staining cultures of live cells. TRITC- or Alexa 488–labeled 
 
a
 
-Btx (2 
 
m
 
g/
ml) was added directly to the media for 1 h at 37
 
8
 
C. Cultures were then
washed twice with PBS and fixed with 2% paraformaldehyde for 15 min at
37
 
8
 
C. This fixation permeablizes a small fraction of the myotubes and oc-
casionally myotubes will be labeled intracellularly (see Fig. 10 A). After
two additional washes with PBS, cells were blocked for 1 h with 10% goat
serum in PBS (blocking buffer). When primary antibodies recognizing in-
tracellular epitopes were used, cells were first permeablized with 0.1%
Triton X-100 in blocking buffer for 10 min at room temperature. Primary
antibodies were diluted in blocking buffer and incubated at room temper-
ature for 1 h. After several washes with PBS, bound primary antibody was
detected with TRITC- or Oregon green 488–conjugated secondary antise-
rum. Cultures were washed a final time before the addition of Immuno
Floure Mounting Medium (ICN Biomedicals) and mounted on coverslips.
Fluorescence was viewed with a ZEISS Axioskop fluorescence micro-
scope. To document observed differences in the intensity of antibody la-
beling, experimental and control samples were photographed and repro-
duced under identical conditions.
 
Quantification of AChR Clusters
 
ES cell cultures were treated for 16 h with agrin (500 pM) or laminin (100
nM) before incubation with fluorescent–
 
a
 
-Btx for 1 h. Labeled cultures
were then washed twice with PBS and fixed with 2% paraformaldehyde
for 15 min. The number of spontaneous or induced AChR clusters was
quantified from data captured on photographic images taken with a
ZEISS Axioskop fluorescence microscope. In each experiment at least 10
nonoverlapping microscope fields from each culture dish and treatment
were examined and the average number of AChR clusters per field was
quantified. Pains were taken to control the number and caliber of myo-
tubes in each field. In all instances no morphological differences were
noted between wild-type R1 myotubes or dystroglycan-null myotubes and
individual experiments were repeated at least three times. The area and
density of AChR clusters on R1, 3C12, and 3H1 cells were quantified us-
ing NIH Image, v1.62, run on a Macintosh G3 (Apple Computer). All
cluster images were scanned at 300 dpi and imported into NIH Image soft-
ware using the scanner interface program FotoLook (v2.07; Agfa) and an
Agfa ArcusII scanner. Photographic images were imported into NIH Im-
age in gray scale mode and were “inverted” so that clusters were set to ap-
pear black on a white background and the size scale calibration was set to
7.35 pixel/
 
m
 
m.
To estimate the density of AChR clusters, the total area occupied by a
cluster was determined by circumscribing them using the Free Hand tool
function of NIH Image and the Measure command. These clusters were
then highlighted using the Density Slice tool and the scale was manipu-
lated so as to accentuate only AChRs within the perimeter of the circum-
scribed cluster. The selected areas were then compared with the original
photographs and the area occupied by AChRs was measured using the
Analyze Particles command. The resulting values were summed to give
the particle area. The AChR cluster density, given as a percentage, was
then derived by dividing the particle area by the total area circumscribed.
At least 50 clusters were analyzed for each cell type.
The extent of overlap of extracellular matrix molecules with AChR
clusters was quantified using a 40
 
3
 
 objective on a ZEISS Axioskop fluo-
rescence microscope. The percentage of overlap was determined for each
field containing at least one AChR cluster. Plaques of extracellular matrix
molecules were considered to overlap with AChRs if the staining for the
molecule was completely within the perimeter of an AChR cluster or vice
versa. Experiments were repeated at least three times with at least six to
seven fields quantified for an extracellular matrix molecule examined in
each experiment. The total number of clusters analyzed exceeded 50 for
each extracellular matrix molecule. Results were compared using Stu-
dent’s 
 
t
 
 test or analysis of variance (ANOVA), as indicated.
 
Results
 
Dystroglycan Depletion in Skeletal Muscle Results in 
Aberrant NMJs
 
In a previous report we described the dystrophic pheno-
type of chimeric mice deficient in dystroglycan and noted
that NMJs, especially in older mice, were disorganized
(Côté et al., 1999). At that time we were unable to rigor-
ously evaluate the amount of dystroglycan expressed at in-
dividual endplates because high levels of endogenous
mouse immunoglobulins were present at the periphery of
wild-type muscle fibers and within degenerating fibers of
chimeric muscle (Côté et al., 1999). This resulted in a very
high level of labeling with the anti–mouse secondary anti-
sera used against the available monoclonal antibody to
 
b
 
-dystroglycan. Thus, in chimeric skeletal muscle, where
each myofiber has hundreds to thousands of nuclei, mus-
cles which appeared to be completely derived from dys-
troglycan-null stem cells, when assayed by the extremely
sensitive method of glucose phosphate isomerase electro-
phoresis (De Lorenzo and Ruddle, 1969), may have had
some residual dystroglycan. To evaluate this, we have gen-
erated and characterized a rabbit antiserum against 
 
b
 
-dys-
troglycan. The specificity of this antibody is shown in an 
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immunoblot (Fig. 1 A), where the antiserum identifies a
single major band at 43 kD, the size of 
 
b
 
-dystroglycan, in
wild-type muscle (Fig. 1 A; lane wt). This band is undetect-
able in muscle extracts from dystroglycan-deficient chime-
ras (Fig. 1 A; lane ch). Also, immunostaining of wild-type
muscles with this antiserum is restricted to the surfaces of
these myofibers (Fig. 1 B) and is blocked by addition of
the peptide used to generate the antiserum (Fig. 1, C and
D). Dystroglycan expression was then assayed by immu-
nohistochemistry on similar muscle sections in conjunction
with fluorescently labeled 
 
a
 
-Btx to identify NMJs. When
viewed en face, we observed endplates on muscle fibers
with variable levels of dystroglycan expression. In many
cases, in younger mice these junctions appeared like those
in muscles from wild-type littermates (Fig. 1, E and E
 
9
 
). In
other cases, there was a large reduction of dystroglycan ex-
trasynaptically and the residual dystroglycan had been re-
cruited to partially disorganized endplates (Fig. 1, F and
F
 
9
 
); in still other cases, there were fibers devoid of any de-
tectable dystroglycan with very diffuse clusters of AChRs
(Fig. 1, G and G
 
9
 
; arrows).
 
Myotubes Generated from Dystroglycan-null ES Cells 
Do Not Form Condensed Clusters of AChRs either 
Spontaneously or in Response to Agrin
 
To assess the roles of dystroglycan in the organization of
the sarcolemma and the organization of AChRs, ES cells
were grown (see Materials and Methods) and allowed to
differentiate for up to 30 d. Under these conditions dystro-
glycan-null ES cells differentiated into several cell types,
including neurons, blood cells, and myoblasts (Côté, P.D.,
and S. Carbonetto, unpublished results). By 20 d in culture
myoblasts had fused into myotubes with multiple aligned
nuclei which expressed myogenin when assayed immuno-
Figure 1. Adult NMJs are disorga-
nized in dystroglycan-deficient mus-
cles. (A) The specificity of the poly-
clonal antiserum used in this study
against b-dystroglycan was tested by
immunoblot of total muscle extracts of
wild-type (wt) and dystroglycan-
depleted chimeric muscle (ch). Addi-
tionally, wild-type muscle sections
were probed immunocytochemically
using either antiserum against b-dys-
troglycan (B) or the antiserum prein-
cubated with 100-fold excess of the
peptide used for immunization (C and
D; phase corresponding to C). Longi-
tudinal sections of the superficial glu-
teal muscle were stained with TRITC–
a-Btx and antisera to b-dystroglycan
(anti-bDG). In muscle fibers with near
normal levels of dystroglycan expres-
sion (E9) there is a concentration of
dystroglycan at endplates in a pattern
corresponding to AChR staining (E)
and equivalent to that seen in wild-
type mice (not shown). In muscle fi-
bers with no detectable extrajunctional
dystroglycan there may be some dys-
troglycan at end-plates (F9) and signifi-
cantly disorganized AChRs (F). In in-
stances where there is no dystroglycan
whatsoever (G9), AChRs are grossly
disorganized and broken up into mi-
croclusters spread over the fiber sur-
face (G). Bar: (B, C, and D) 100 mm;
(E, F, and G) 30 mm. 
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cytochemically (data not shown). Myotubes in cultures of
wild-type (R1) and dystroglycan-null ES cell lines (3C12
and 3H1) were indistinguishable under phase optics (Fig. 2
A, left) and contracted spontaneously. After incubation
with TRITC-labeled 
 
a
 
-Btx, wild-type and dystroglycan-
null myotubes were both found to have AChR clusters,
though there was a clear difference in their morphology.
AChRs from wild-type (R1) myotubes were in tight, uni-
formly fluorescent clusters, whereas clusters of AChRs on
dystroglycan-null myotubes (3C12 and 3H1) were punc-
tate and covered a larger area than those on wild-type myo-
tubes (Fig. 2 A). Similar results were obtained whether
clusters had formed spontaneously or were induced by
agrin (Fig. 2 A). The small clusters of AChRs appeared
similar to the microclusters that first form on the surface
of muscle after innervation and which are known to con-
tain dystroglycan (Cohen et al., 1995). Based on these ob-
servations, we hypothesized that dystroglycan either was
necessary for the condensation of AChR microclusters
into larger clusters, or was required for stabilization of
preexisting clusters which had formed normally but then
dispersed in the absence of dystroglycan.
To distinguish between these two possibilities, we
treated cultures with agrin and monitored the onset of
AChR clustering. From the earliest time points at which
they were visible (8 h), clusters induced by agrin (500 pM)
on 3C12 and 3H1 cells were more diffuse than those on
wild-type R1 cells. On 3C12 cells there was no evidence of
normal-looking AChR clusters which would subsequently
disperse into microclusters. In addition to the difference in
distribution of AChR clusters, there was also a decrease in
 
their number on dystroglycan-null myotubes treated with
agrin. There were 12.1 clusters per field on R1 cells and
only 8.0 and 9.0 clusters per field on 3C12 and 3H1 myo-
tubes, respectively (Fig. 2 B). The reduction in the number
of AChR clusters on the two dystroglycan-null lines 3C12
and 3H1 was statistically significant when individually
compared with R1 cells (
 
P 
 
,
 
 0.01; 
 
n
 
 
 
$ 
 
3). However, in all
three cell lines there was an approximately fourfold in-
crease in the number of clusters on cells treated with agrin
compared with untreated controls.
Detailed morphometric analysis allowed quantification
of the differences in size and density of AChR clusters on
R1 and 3C12 myotubes. Cluster area was determined for
untreated and agrin-treated R1 and 3C12 myotubes, and
the resulting values were used to calculate the average clus-
ter size as well as to generate a frequency distribution of
cluster areas (Fig. 3 A). Agrin treatment of wild-type (R1)
and null (3C12) myotubes resulted in a much larger in-
crease in AChR cluster area in 3C12 cells (13.69 to 31.35
 
m
 
m
 
2
 
) than in R1 cells (6.93 to 10.3 
 
m
 
m
 
2
 
; Fig. 3 A, broken
line). The increase in area with agrin treatment within a cell
line and the difference in areas between the two differ-
ent lines were statistically significant (
 
P 
 
,
 
 0.0001). The dif-
ference in AChR density was quantified by determining
the ratio of surface area covered with 
 
a
 
-Btx fluorescence to
nonfluorescent area within the perimeter occupied by indi-
vidual R1 and 3C12 AChR clusters. AChRs occupied
 
z
 
63% of the area within the perimeter of a wild-type
AChR cluster (Fig. 3 B), which was approximately double
the 28–30% of the area that receptors occupied in each dys-
troglycan-null myotube cluster (
 
P 
 
,
 
 0.0001; 
 
n
 
 
 
.
 
 50). The
Figure 2. Dystroglycan-null myotubes have
AChR clusters on their surface and respond to
agrin. Wild-type (R1) and dystroglycan-null
(3C12 and 3H1) ES cells were differentiated in
culture for up to 30 d to generate spontaneously
contracting myotubes (A, left). When cells were
treated with agrin and stained with TRITC–
a-Btx, AChR clusters were observed on the sur-
faces of all three differentiated ES cell lines.
Dystroglycan-null myotubes (3C12 and 3H1) have AChR clusters comprised of diffuse arrays of microclusters. This contrasts with the
AChR clusters on R1 cells, which are in smaller and more uniformly fluorescent plaques (A, right). (B) Overnight treatments with 500
pM agrin induced an approximately fourfold increase in the number of clusters for all three cell lines compared with untreated cultures.
The data presented represent at least three separate experiments with 10–20 microscope fields of myotubes quantified per experiment.
Significance was tested using Student’s t test. Bar, 10 mm. 
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relative level of AChR expression on each ES cell line was
estimated by multiplying the number of clusters within
each microscope field (Fig. 2) by the average cluster area
for each cell type (Fig. 3 A) and the density of AChRs (see
above). By this measure the area covered by AChRs on
R1, 3C12,and 3H1 myotubes was 78.71, 70.22, and 89.73
 
m
 
m
 
2
 
, respectively. When expressed relative to values on R1
cells, the values on null myotubes were approximately com-
parable, being 89% (3C12) or 114% (3H1) of the levels on
R1 cells. The lack of dystroglycan thus resulted in AChR
clusters which were three times larger and twice as diffuse
as those found on wild-type cells, though the myotubes ap-
peared to contain similar numbers of AChRs. Taken to-
gether, these data suggest that dystroglycan-null cells were
able to respond to agrin initially to form microclusters but
unable to condense them into larger, synaptic-like clusters.
Figure 3. AChR cluster area and density is al-
tered in dystroglycan-null myotubes. (A) The
histograms show size distributions for the wild-
type (R1) and dystroglycan-null (3C12) cells
lines in untreated cultures (Control) or in cul-
tures treated with 500 pM agrin or 100 nM lami-
nin. The average cluster area is represented by
the peak of the dashed line on each graph. Agrin
and laminin treatment of R1 cells resulted in an
increase in cluster area from 6.9 to 10.3 and 17.6
mm2, respectively. A larger increase in AChR
cluster size was noted for agrin-treated 3C12
cells, 31.4 mm2, up from 13.7 mm2. Laminin in-
creased the size of clusters on R1 cells but was
ineffective on 3C12 cells. At least 10 microscope
fields containing AChR clusters were quantified
in five separate experiments for each cell line
and treatment. (B) The density of AChR clusters
was estimated (see Materials and Methods) for
the three cell lines after agrin treatment. AChR
clusters on 3C12 and 3H1 cells were twice as dif-
fuse as those on R1 cells. AChRs covered 28 and
30% of the area within clusters on dystroglycan-
null myotubes versus 63% of the area on wild-
type clusters. At least 50 clusters were quantified
per cell line over five experiments to determine
AChR density and the significance tested using a
Student’s t test (P , 0.0001).
Figure 4. AChR cluster stability is reduced in dystroglycan-null myotubes.
Differentiated ES cells were incubated overnight with or without 500 pM
agrin, washed, then maintained in fresh medium. Cultures were labeled with
TRITC–a-Btx at 0, 4, and 8 h after washing, fixed, and the number of AChR
clusters per field was determined. The number of spontaneous clusters in un-
treated cultures was subtracted from each of the agrin treated time points and
the resulting value was expressed as a percentage of the value at time zero.
AChR clusters on 3C12 cells dispersed at approximately three times the rate
of clusters on wild-type cells. By 8 h there was an 88% drop in the number of
AChR aggregates on 3C12 cells (filled circles), compared with a 27% drop on
R1 cells (open circles). There was no significant difference between the num-
ber of clusters remaining on 3C12 cells at 8 h and on untreated cultures. The
data represent the average of three trials. Significance was tested by ANOVA
(P , 0.0001).Jacobson et al. The Role of Dystroglycan in Synapse Formation 441
Dystroglycans Increase the Stability of AChR Clusters
In view of its position as a transmembrane complex and its
role in condensing AChRs, it is reasonable to propose that
a- and b-dystroglycan contribute to the stabilization of
AChR clusters once formed. Cluster stability was deter-
mined by quantifying the number of AChR clusters on
wild-type and dystroglycan-null myotubes after treatment
overnight with 500 pM agrin, then replacing the agrin-con-
taining medium with fresh medium and assaying the num-
ber of AChR clusters after 0, 4, or 8 h. Within 4 h there
was a significant difference in the number of AChR clus-
ters on R1- and 3C12-derived myotubes (Fig. 4). Clusters
on R1 cells had decreased by 11%, but on 3C12 cells by
62%. This downward trend continued, with R1 myotubes
declining a further 16% and 3C12 myotubes 26% by 8 h
(Fig. 4). Indeed, by 8 h, the vast majority of agrin-induced
AChR clusters remained on R1 cells, whereas they had es-
sentially dispersed on 3C12 cells. These data suggest that
condensation of AChR clusters mediated by dystroglycan
enhanced their stability.
Agrin and Rapsyn Colocalize with AChR Clusters 
Independently of Dystroglycan
Agrin binds directly to a-dystroglycan (Bowe et al., 1994;
Campanelli et al., 1994; Gee et al., 1994; Sugiyama et al.,
1994) and is found in microcluster of AChRs within 1 h of
synapse formation (Cohen et al., 1995). In addition, b-dys-
troglycan has been reported to aggregate with rapsyn and
AChRs when coexpressed in heterologous cells and to
bind to rapsyn in biochemical assays (Apel et al., 1995;
Cartaud et al., 1998). We examined whether the microclus-
ters on dystroglycan-null cells were similar in composition
Figure 5. Agrin and rapsyn colocalize with AChR clusters on dystroglycan-null myotubes. Myotubes from wild-type (R1) and dystro-
glycan-null ES cells (3C12) were treated overnight with 500 pM agrin and stained with TRITC–a-Btx and either antiagrin or antirapsyn
antibodies. In both cell types there is colocalization of AChR clusters with agrin (arrows in A, A9, B, and B9) and with rapsyn (arrows in
C, C9, D, and D9). The percentage overlap (E and F) indicates the percentage of AChR clusters with corresponding concentrations of
agrin and rapsyn. In both 3C12 and R1 lines we found no significant difference in the level of colocalization of AChR aggregates with
agrin (E) or rapsyn (F). The histograms represent the average of three separate experiments in which 10–20 microscopic fields contain-
ing at least one AChR cluster per field. Bar, 10 mm.The Journal of Cell Biology, Volume 152, 2001 442
to those at nascent synapses and whether they contained
agrin. Fixed ES cell myotubes were stained with an anti-
agrin polyclonal antiserum in conjunction with live staining
with TRITC–a-Btx to determine whether agrin codistrib-
uted with AChR clusters. We found that agrin was local-
ized to AChR clusters on wild-type (R1) myotubes (Fig. 5,
A and A9) as well as dystroglycan-null (3C12) myotubes
(Fig. 5, B and B9). R1 and 3C12 cells had 88.9 6 4.0% and
81.7 6 8.0% overlap of agrin labeling with AChR clusters,
respectively (Fig. 5 E). Antirapsyn antibodies labeled
91.7 6 8.3% of R1 AChR clusters (Fig. 5, C, C9, D, and
D9) and 75 6 13.1% of 3C12 clusters (Fig. 5 F). However,
despite similar levels of colocalization there were differ-
ences in the intensity and distribution of rapsyn staining in
3C12 myotubes. In wild-type myotubes rapsyn was evenly
distributed throughout each AChR cluster, but in dystro-
glycan-null myotubes rapsyn was restricted to the largest
and brightest regions of all clusters. The presence of agrin
and rapsyn in microclusters of AChRs in dystroglycan-null
cells is consistent with the notion that these are microclus-
ters similar to those at developing NMJs and suggest that
they are localized there independent of dystroglycan.
The Synaptic Extracellular Matrix Is Disorganized in 
Distroglycan-null Myotubes
In view of reports (Montanaro et al., 1998; Peng et al.,
1998, 1999) that a-dystroglycan is a receptor for laminin,
perlecan, and indirectly AChE, all of which are important
components of the synaptic basement membrane, we ex-
amined the distribution of these molecules in differenti-
Figure 6. Laminin colocalization with AChR aggregates is disrupted on dystroglycan-null myotubes. Wild-type (R1) and dystroglycan-
null myotubes (3C12) were treated overnight with 500 pM agrin and subsequently fixed and stained for AChRs in conjunction with ei-
ther anti–EHS laminin (A, A9, B, and B9) or antilaminin a2 chain (merosin) antibodies (C, C9, D, and D9). The filled arrows in all panels
indicate the location of AChR clusters (A–D), laminin (A9 and B9), or merosin (C9 and D9). AChR clusters on the tops of wild-type myo-
tubes contained both laminin and merosin whereas those on dystroglycan-null cells have little or no laminin and merosin. We did note
some ribbons of AChRs along the sides of myotubes which contain laminin (open arrows). The amount of overlap with AChR clusters
for each laminin isoform is shown in E and F. Histograms represent the quantification of three separate experiments with 10–20 micro-
scope fields containing at least one AChR cluster per field. Significance was determined using Student’s t test (*P , 0.0001). Bar, 10 mm.Jacobson et al. The Role of Dystroglycan in Synapse Formation 443
ated ES cell cultures null for dystroglycan. We initially
stained myotubes with two laminin-specific antibodies.
With an antiserum to EHS laminin, staining was found to
be highly concentrated at AChR clusters in wild-type
myotubes (Fig. 6, A and A9), but not in dystroglycan-null
myotubes (Fig. 6, B and B9). In many cases the size and
shape of the of these laminin clusters mirrored that of the
underlying AChRs. Laminin colocalized with AChRs on
wild-type (92.1 6 2.6%) and dystroglycan-null (16.3 6
6.0%) myotubes (Fig. 6 E). Similar results were obtained
with antiserum specific for the laminin a2 chain (Fig. 6, C,
C9, D, and D9): the a chain is part of laminins 2 and 4,
which are the predominant isoforms on the muscle surface
(Ehrig et al., 1990). When quantified, laminin a2 staining
overlapped with 90 6 4.3% of AChR clusters on R1 myo-
tubes and 20 6 10.7% on the surface of 3C12 myotubes
(Fig. 6 F).
Perlecan is another extracellular matrix molecule con-
centrated at the NMJ early during differentiation (Bayne
et al., 1984; Anderson, 1986). In ES cell myotubes perlecan
colocalization with AChRs was dependent on dystrogly-
can expression. Perlecan was found to be highly colocal-
ized with AChRs in R1 myotubes (Fig. 7, A and A9) and
the absence of dystroglycan resulted in the loss of perlecan
at AChR clusters (Fig. 7, B and B9). Quantitatively, perle-
can colocalized with AChRs in 72.9 6 12% of clusters in
wild-type cells and only 10.7 6 7.7% in null myotubes (Fig.
7 E). The loss of perlecan might be expected to affect the
distribution of AChE, which can bind to perlecan and is
localized to NMJs and AChR clusters (Peng et al., 1999).
Wild-type and dystroglycan-null myotubes stained with
TRITC–a-Btx and Oregon green fas-2 to label AChE re-
vealed AChE at 73.3 6 11.7% of R1 AChR clusters (Fig.
7, C, C9, and F), but only 8.3 6 5.6% of 3C12 AChR clus-
ters (Fig. 7, D, D9, and F). We also examined the distribu-
tion of AChRs and AChE in teased muscle fibers of dys-
troglycan-deficient chimeric mice. As shown in Fig. 1, and
for reasons explained earlier, we observed a gradation in
Figure 7. Perlecan and AChE do not colocalize with AChR clusters in dystroglycan-null myotubes. Agrin-induced (500 pM overnight)
wild-type (R1) and dystroglycan-null (3C12) myotubes were stained with TRITC–a-Btx in conjunction with antiperlecan antibodies or
fas-2, a fluorescently labeled AChE-specific toxin. The arrows indicate AChR clusters in A–D, perlecan staining in A9 and B9, and
AChE staining in C9 and D9. Perlecan and AChE do not colocalize with AChR clusters in dystroglycan-null (3C12) myotubes. The level
of colocalization is reflected in the histograms at the right (E and F). The data represented in the histograms were collected as above
with the significance determined using Student t test (*P , 0.0001). Bar, 10 mm.The Journal of Cell Biology, Volume 152, 2001 444
the disruption of NMJs after labeling with TRITC–a-Btx,
reflecting the level of dystroglycan expression at the junc-
tion. These defects ranged from very mild (Fig. 8 B),
where synaptic gutters or folds in the postsynaptic mem-
brane were abundant and similar in intensity, to wild-type
staining at the edges (Fig. 8 A), to very severe (Fig. 8 D)
with no distinguishable gutters and punctate AChR label-
ing. The intensity of fas-2 staining was correlated with the
level of disruption of the AChR distribution. When AChR
staining was strong, fas-2 staining was intense and its dis-
tribution matched that of a-Btx along the synaptic gutters
(Fig. 8 B9), as in wild-type muscle (Fig. 8 A9). However,
when the AChR distribution was abnormal, fas-2 staining
was either weak (Fig. 8 C9) or completely absent (Fig. 8
D9), indicating that AChE localization was dependent on
dystroglycan expression at NMJs as at AChR clusters in
culture.
In dystroglycan-deficient muscle the size of the nerve
terminal, as shown by immunohistochemistry for the syn-
aptic vesicle protein synaptophysin, was also affected (Fig.
9). When compared with wild-type AChR clusters and
nerve terminals (Fig. 9, A and A9, respectively), endplates
from chimeric animals (n 5 3) could be found that were
larger with obviously disorganized AChR clusters (Fig. 9
B) and a similarly large area of synaptophysin staining
(Fig. 9 B9). These results suggest that dystroglycan not
only was necessary for the localization of several basement
membrane components to the synapse, but also might di-
rectly or indirectly regulate alignment between the pre-
and postsynaptic specializations.
In contrast to the distribution of AChR clusters in cul-
ture, the distribution of laminin, perlecan, agrin, colla-
gen IV, and fibronectin over the remaining surface of myo-
tubes was grossly the same on all lines of cultured ES
cells (Fig. 10). This is consistent with their distribution in
the extrajunctional muscle of dystroglycan-deficient mice
(Côté et al., 1999). However, on close examination there
was evidence of a difference in the pattern of laminin
Figure 8. AChE distribution is altered
at the endplates of dystroglycan-defi-
cient chimeric mouse muscle. Teased
muscle fibers from wild-type (A) and
chimeric mice (B–D) were isolated and
stained with TRITC–a-Btx and fas-2.
AChR labeling at endplates varies
from nearly normal (B) to severely de-
pleted (C and D). AChE staining is
similarly graded and is virtually lost
from the most severely disorganized
endplates (C9 and D9). The arrows in
D and D9 point to punctate aggregates
of AChR and the sites to which AChE
should be localized within the same
field respectively. Bar, 10 mm.Jacobson et al. The Role of Dystroglycan in Synapse Formation 445
staining on the surface of cells. Wild-type myotubes ap-
peared to have large plaques of laminin on the surfaces
(Fig. 10, arrow), whereas these plaques were absent on
dystroglycan-null cells and the laminin is more fibrillar in
appearance (Fig. 10, A and A9). Perlecan staining was the
same on myotubes derived from wild-type or null ES cells,
and was diffuse over the cell surface (Fig. 10, B and B9)
with very little perlecan bound to myotubes outside of
AChR clusters. Collagen IV and fibronectin staining was
also unaffected by the lack of dystroglycan and was uni-
formly filamentous over wild-type and null myotubes (Fig.
10, C, C9, D, and D9). Finally, agrin staining was diffusely
distributed over most of the myotubes, with some concen-
trations found at the edges of myotubes in both cell types
(Fig. 10, E and E9). Together, these results suggest that the
expression of extracellular matrix proteins is essentially
normal over most of the myotube surface in the absence of
dystroglycan (Côté et al., 1999) despite clear defects
within AChR clusters.
AChR Clusters Induced by Laminin Are Defective on 
Dystroglycan-null Myotubes
The absence of laminin, but not agrin (compare Fig. 5, top,
to Fig. 6), from AChR clusters suggested that laminin,
rather than agrin, bound to dystroglycan participates in
the condensation of microclusters of AChRs into larger
clusters. To test this possibility, we examined the effect of
exogenously added laminin on AChR clustering on R1
and 3C12 myotubes. Laminin induced the formation of
AChR clusters on the surface of myotubes derived from
wild-type ES cells, but not on dystroglycan-null myotubes
(Fig. 11). Laminin-treated R1 cells had 7.2 vs. 3.2 clusters
per field in untreated myotubes, whereas dystroglycan-
null 3C12 myotubes treated with laminin had 1.5 vs. 2.3
clusters per field in untreated cultures (P , 0.001, n 5 3).
Laminin-induced AChR clusters on R1 myotubes (Fig. 3,
bottom left) were z1.7 times larger (17.6 mm2) than those
induced by agrin (10.3 mm2; P , 0.0001, n 5 50). In com-
parison, AChR clusters on laminin-treated 3C12 cells
(11.4  mm2) were similar in appearance (compare Fig. 3 A,
top right with bottom right) and size to spontaneous clus-
ters (13.7 mm2) on untreated cells. The inability of laminin
to induce AChR clusters on dystroglycan-null myotubes,
in combination with the change in appearance of sponta-
neous and agrin-induced clusters, suggested that laminin–
dystroglycan interactions were important in the formation
of dense AChR clusters and that disruption of these inter-
actions is responsible for the diffuse, unstable clusters in
culture and in vivo.
Discussion
ES cells with targeted disruptions in both dystroglycan al-
leles were used to generate chimeric mice deficient in dys-
troglycan and to form myotubes devoid of dystroglycan.
Using these two systems, we have found that dystroglycans
are necessary for the condensation of AChR microclusters
and stabilization of AChRs within the plasma membrane,
as well as for the assembly of normal synaptic components,
including AChE. These results highlight the importance of
DAPs in multiple aspects of synapse formation.
DAPs Are Necessary for the Formation of AChR 
Clusters in Culture and NMJs
In previous studies, we and others have found that DAPs
are involved in agrin-induced AChR clustering (Campa-
nelli et al., 1994; Gee et al., 1994; Jacobson et al., 1998;
Montanaro et al., 1998; Grady et al., 2000) and we recently
reported initial observations that dystrophic mice deficient
in dystroglycan had disorganized NMJs (Côté et al., 1999).
Here we have focused on the NMJs and analyzed muscle
from young chimeric animals (3–12-wk-old) whose mus-
cles showed minimal signs of muscular dystrophy. The ani-
mals did not show any obvious muscle weakness as they
walked, or the waddling gait described previously (Côté et
al., 1999) and histological examination revealed few de-
generating fibers, evident by their small diameter with dis-
rupted myofibrillar apparatus, and few regenerating fibers
with central nuclei. In these animals there was a graded
disruption of synapses, reflecting the level of dystroglycan
expressed (Fig. 1). Similarities in the synaptic defects at
NMJs in chimeric mice and in myotubes in culture, which
lack any dystroglycan, argue that deficiencies in dystrogly-
can in the muscle fiber per se and not in the innervating
neuron or surrounding Schwann cells (Yamada et al.,
1996a,b) are responsible for defective NMJs.
AChR clusters on dystroglycan-null myotubes were
three times larger (Fig. 3 A), but had approximately half
the AChR density compared with clusters on wild-type
myotubes (Fig. 3 B). In previous studies with C2C12 mus-
cle cell lines that had reduced levels of dystroglycan as a
result of the introduction of an antisense cDNA, we re-
ported that there was a corresponding decrease in the
number of AChR clusters after agrin treatment (Jacobson
Figure 9. Nerve terminal size correlates with AChR distribution
in dystroglycan-deficient chimeric mice. Longitudinal sections
from wild-type (A and A9) and chimeric mice (B and B9) were
stained with TRITC–a-Btx and antisynaptophysin antisera to la-
bel nerve terminals. Synaptophysin staining and AChR aggre-
gates were found to be in precise alignment at synapses in both
wild-type and dystroglycan-deficient muscle, whereas nerve ter-
minals on dystroglycan-deficient myofibers appeared enlarged
(compare A and A9 with B and B9). Bar, 10 mm.The Journal of Cell Biology, Volume 152, 2001 446
et al., 1998). It is important to note that in this earlier study
clusters  ,2.5  mm in diameter were not counted, which
would have excluded the microclusters that predominate
on dystroglycan-null myotubes (Jacobson et al., 1998) and
this likely accounts for the apparent reduction in clusters
on myotubes immediately after agrin treatment not seen in
the present study. The AChR microclusters on dystrogly-
can-null myotubes are similar in appearance to those ob-
served by Campanelli et al. (1994) using a monoclonal anti-
body to inhibit a-dystroglycan function (Gee et al., 1994),
as well as to the microclusters seen at early stages of synap-
togenesis (Anderson and Cohen, 1977; Steinbach, 1981) or
induced by rapsyn in heterologous cells (Froehner et al.,
1990; Phillips et al., 1991b). These rapsyn-containing mi-
croclusters appear to form a subunit of the mature postsyn-
aptic density of AChRs which are knit together by DAPs.
The 25–33% decrease in the number of AChR clusters
on dystroglycan-null versus wild-type myotubes probably
results from their diffuse nature and increased size rather
than a difference in AChR levels and response to agrin.
With no clear boundaries, counts of clusters on dystrogly-
can-null myotubes may have been skewed toward lower
absolute numbers. This is supported by previous studies in
dystroglycan-deficient C2C12 cells, where we found simi-
lar levels of agrin induction (Fig. 2 B) and little difference
in MuSK and AChR b-subunit phosphorylation (Jacobson
et al., 1998), implying that dystroglycan depletion has little
or no effect on agrin signaling. The diffuse appearance of
AChR clusters on dystroglycan-null myotubes could then
reflect either a failure of large dense clusters to form or
their rapid dispersal once formed. In dystroglycan-null
cells, we found no evidence for condensed clusters. More-
over, the AChR clusters on dystroglycan-null myotubes
were also less stable than wild-type AChR clusters and, on
removal of agrin, dispersed at approximately twice the
rate as those in wild-type cultures. In principle, this insta-
bility may result from increased turnover of receptors in
microclusters or diffusion of receptors away from them.
Xu and Salpeter (1997) reported that the degradation of
AChRs in denervated muscle devoid of dystrophin is in-
creased and this may obtain in dystroglycan-null myo-
tubes.
In related work, Grady et al. (2000) reported that the
DAP dystrobrevin is also necessary for NMJ formation.
Figure 10. The distribution of various basement
membrane molecules on myotubes derived from
wild-type and dystroglycan-null ES cells. Wild-
type (R1) and dystroglycan-null myotubes
(3C12) were fixed gently and stained with anti-
bodies for the basement membrane molecules
laminin, perlecan, collagen IV, fibronectin, and
agrin. Occasionally this fixation permeablizes
myotubes, which results in some intracellular la-
beling that highlights nuclei (A, left corner),
though the vast majority of the cells in this and
other panels show surface labeling and have no
visible intracellular labeling. Photomicrographs
were taken of fields of myotubes lacking AChR
clusters. Over most of the sarcolemma there ap-
peared to be few morphological differences in
basement membranes of wild-type and dystro-
glycan-null myotubes, with the exception of
laminin, which was found consistently to form
large plaques on wild-type myotubes (arrow in
A), but not on dystroglycan-null myotubes (A9).Jacobson et al. The Role of Dystroglycan in Synapse Formation 447
The distribution of AChRs in dystrobrevin null mice ap-
pears similar to that of AChRs in dystroglycan-null myo-
tubes, as shown here and as reported previously by Grady
et al. (2000), as well as to the distribution in vivo (Côté et
al., 1999). Our data on dystroglycan-null myotubes in cul-
ture extend those of Grady et al. (2000) by quantifying the
changes in AChR clusters, synaptic basement membrane
proteins, while also measuring the effects of agrin treat-
ment and the stability of induced AChR clusters. Interest-
ingly, AChRs on dystrobrevin null myotubes are unstable,
similar to those in dystroglycan-null myotubes (Fig. 4) and
dystroglycan is present in AChRs lacking dystrobrevin
(Grady et al., 2000). This suggests that dystroglycan is up-
stream of dystrobrevin in the pathway responsible for
AChR aggregation/stabilization.
Rapsyn is a 43-kD intracellular protein that is associated
with AChRs (Sobel et al., 1977; Froehner et al., 1981; Bur-
den et al., 1983). This association, in conjunction with
rapsyn aggregation, contributes to the formation of mi-
croclusters of AChRs when both are expressed in heterol-
ogous cells (Froehner et al., 1990; Phillips et al., 1991b).
Moreover, mice with a targeted mutation in the rapsyn
gene have NMJs with diffusely organized AChRs (Gau-
tam et al., 1995). Rapsyn can bind directly to b-dystrogly-
can (Cartaud et al., 1998) and when coexpressed with dys-
troglycan in heterologous cells has been reported to
recruit dystroglycan into AChR-rich microclusters (Apel
and Merlie, 1995). Thus, b-dystroglycan has been hypothe-
sized to mediate interactions with rapsyn important to
AChR clustering. In our studies rapsyn was localized to
AChR clusters in both the R1 and 3C12 cell lines, al-
though in null myotubes rapsyn staining was reduced or
absent outside of intense areas of AChR localization (Fig.
5, C9 and D9). These results suggest that some fraction of
rapsyn may interact with b-dystroglycan, but that this in-
teraction is not necessary for localization of rapsyn within
AChR clusters.
Dystroglycan Organizes Rapsyn, AChE, Perlecan, and 
Laminin at the NMJ
Asymmetric isoforms of AChE are tightly bound within
the basement membrane through interactions of their col-
lagen-like tail with heparan sulfate proteoglycans (Rossi
and Rotundo, 1996), in particular perlecan (Peng et al.,
1999). Perlecan is concentrated at NMJs in vitro where it is
thought to bind to dystroglycan via its laminin-like G do-
mains (Peng et al., 1998). We have found that both perle-
can and AChE are depleted at AChR clusters in vitro
(Fig. 7) and that AChE was depleted in vivo  (Fig. 8),
which strongly suggests that this interaction occurs in situ.
However, perlecan is expressed at high levels throughout
the entire basement membrane and in prior studies there
was no obvious reduction in its levels in dystroglycan-defi-
cient muscle in vivo (Côté et al., 1999). This may occur be-
cause perlecan is concentrated early during synapse for-
mation (Bayne et al., 1984; Anderson, 1986) and this
concentration is later occluded by deposition of perlecan
in the extrajunctional basement membrane. For example,
the concentration of a-dystroglycan at mouse NMJs is
sometimes difficult to resolve, but is obvious in the muscle
of mdx mice where the extrajunctional dystroglycan is
very low (Leschziner et al., 2000).
Dystroglycan was originally isolated as a component of
the DAP complex (Yoshida and Ozawa, 1990; Ervasti et
al., 1991) and individually as a high affinity laminin binding
protein (Smalheiser and Schwartz, 1987; Douville et al.,
1988; Ibraghimov-Beskrovnaya et al., 1992; Gee et al.,
1993). Subsequently, several lines of evidence suggested
that a-dystroglycan mediates AChR clustering, including
binding of agrin to a-dystroglycan (Campanelli et al., 1994;
Gee et al., 1994; Sugiyama et al., 1994), colocalization of
a-dystroglycan, agrin, and AChRs at developing and ma-
ture synapses (Cohen et al., 1995), and reduced AChR
clustering in dystroglycan antisense lines (Jacobson et al.,
1998). Hence, it is somewhat surprising that even in the ab-
sence of dystroglycan, agrin was still associated with up-
wards of 82% of AChR clusters (Fig. 5, top). Either dystro-
glycan does not function as an agrin receptor in AChR
clustering, or several other molecules compensate for it.
Both the MuSK/myotube-associated specificity component
(MASC) receptor complex (Glass et al., 1996) and the avb1
integrin (Martin and Sanes, 1997) bind to agrin and may lo-
calize it to the synapse in the absence of dystroglycan.
In contrast to the distribution of agrin in culture, we
found that laminin, specifically laminins 2 and 4, which
contain the a2 chain, were no longer concentrated at
AChR clusters on the surface of dystroglycan-null myo-
tubes (Fig. 6). We were also unable to induce the aggrega-
tion AChRs by application of exogenous laminin on these
same myotubes (Fig. 11). Dystroglycan thus appears to be
the primary receptor for laminin at the synapse. This result
confirms results generated by Montanaro et al. (1998) in
C2C12 cells expressing reduced levels of dystroglycan, but
without the complication presented by residual dystrogly-
Figure 11. Laminin induces AChR clusters on myotubes derived
from wild-type (R1) but not dystroglycan-null (3C12) ES cells.
Cultures were treated overnight with either 500 pM of agrin or
100 nM EHS laminin, or left untreated (control). The cultures
were then stained with a-Btx and the number of AChR aggre-
gates quantified. Agrin and laminin induced a significant increase
in the number of AChR clusters on R1 cells but only agrin was
effective in inducing clusters on 3C12 myotubes (ANOVA, P ,
0.001, n 5 3) The values represent the mean 6 SD of three indi-
vidual experiments in which at least 10 microscopic fields per
treatment were quantified.The Journal of Cell Biology, Volume 152, 2001 448
can expression in C2C12 cells. In vivo, the absence of lami-
nins has been correlated with minor defects in nerve termi-
nal structure and function (Carbonetto, 1977; Noakes et
al., 1995). In fact, the nerve terminals on dystroglycan-null
muscle in vivo can be larger, corresponding to the larger
size of the endplate (Fig. 9). For future work, we are pro-
ducing reagents that will allow colocalization of synapto-
physin, dystroglycan, and AChRs in the same histological
sections to correlate differences in synaptic morphology
with the expression of dystroglycan in the muscle. It is
well-known that developmentally the size of nerve termi-
nals is matched to that of the muscle fiber, presumably to
ensure sufficient release of neurotransmitter to activate the
muscle (Kuno et al., 1971). Dystroglycan may contribute to
this regulation either directly or indirectly through laminin.
We also analyzed the staining of extracellular matrix
molecules over extrajunctional regions of myotubes in
wild-type and dystroglycan-null myotubes to determine
whether dystroglycan gene ablation had a significant effect
on the basement membrane. Previously, several groups
have shown that the depletion of the dystrophin–glycopro-
tein complex appears to have little effect on the gross for-
mation of the basement membrane in vivo (Dickson et al.,
1992; Matsumura et al., 1993; Côté et al., 1999). Outside of
AChR clusters the expression of laminin, perlecan, col-
lagen IV, fibronectin, and agrin on myotubes was rela-
tively normal, with the exception (Fig. 10) that laminin
was no longer found as plaques on the surface of null myo-
tubes, but rather in fibrils (compare Fig. 10 A with 10 A9).
Cohen et al. (1997) and Montanaro et al. (1999) found that
dystroglycan was associated with similar plaques in Xeno-
pus and C2C12 cultures. These plaques have been pro-
posed to reflect sites of basement membrane assembly
wherein laminin is concentrated at the membrane by bind-
ing to a-dystroglycan and enhances the polymerization of
extracellular matrix proteins (Cohen et al., 1997; Monta-
naro et al., 1998; Colognato et al., 1999).
A Role for Dystroglycan in Synapse Formation
Several groups have shown that it is possible to bypass
agrin signaling and to stimulate the formation of large
AChR clusters by the addition of laminin (Vogel et al.,
1983; Sugiyama et al., 1997; Montanaro et al., 1998) and
that this clustering is mediated by dystroglycan (Monta-
naro et al., 1998; Fig. 10). Since laminin is deficient from
AChR clusters on dystroglycan-null myotubes, these data
suggest that a-dystroglycan functions as a laminin receptor
in AChR clustering. These results also raise questions con-
cerning the mechanism of condensation and stabilization
of AChRs. Laminin can self-assemble in solution via its
short arms (Yurchenco et al., 1985) and this also occurs on
the muscle cell surface (Cohen et al., 1997). Interestingly,
laminin treatment of myotubes, together with an antilami-
nin antiserum, results in much smaller clusters of AChRs,
similar to microclusters (Montanaro et al., 1998), possibly
because of inhibition of homophilic binding of the laminin
short arms. Thus, an essential aspect of the synapse forma-
tion appears to involve binding of laminin to dystroglycan
and its assembly with other proteins within the basement
membrane. Our studies suggest that this is the case for
AChE, which binds dystroglycan indirectly through perle-
can (Figs. 7 and 8). One could imagine that assembly of a
basement membrane through dystroglycans contributes to
a diffusion trap for synaptic proteins by mediating coordi-
nate assembly of a cytoskeletal matrix. As such, dystrogly-
cans are uniquely suited to bring DAPs into the trap. We
propose a model (Fig. 12) wherein dystroglycans are pref-
erentially clustered to synaptic sites via activation of
MuSK and the resulting density of dystroglycan facilitates
interactions with laminin and perlecan, as well as between
perlecan and AChE, to assemble a synaptic basement
membrane at the same time that b-dystroglycan contrib-
utes to the formation of a cytoskeletal network responsi-
ble for condensation and stabilization of AChRs.
Figure 12. A model illustrating the role of dystroglycan in the
condensation of AChR microclusters and the localization of spe-
cific synaptic basement membrane molecules. On uninnervated
myotubes components of the postsynaptic apparatus are diffusely
distributed throughout the sarcolemma (top). The subsequent
binding of agrin to the MuSK receptor complex initiates a cas-
cade of events (middle) that induces the formation AChR micro-
clusters and the clustering of cytoskeletal and basement mem-
brane molecules such as laminin, perlecan, and AChE. These
microclusters continue to condense into larger clusters through
the recruitment of dystroglycan and associated basement mem-
brane and cytoskeleton components resulting in a more stable
cluster of AChRs (bottom).Jacobson et al. The Role of Dystroglycan in Synapse Formation 449
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